[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-studies-list:{\"overallStatus\":[\"RECRUITING\",\"AVAILABLE\",\"NOT_YET_RECRUITING\"],\"leadSponsorName\":\"Lacer S.A.\",\"orderBy\":\"LastUpdateSubmitDate:desc\",\"size\":25,\"offset\":0}":3,"health-study-condition:":103},{"pageToken":4,"total":5,"offset":6,"count":5,"results":7},null,4,0,[8,42,63,82],{"id":9,"slug":10,"hasResults":11,"nctId":12,"briefTitle":13,"officialTitle":14,"acronym":4,"eligibilityCriteria":15,"healthyVolunteers":16,"sex":17,"minAge":18,"maxAge":19,"enrollmentInfo":20,"targetDuration":4,"studyType":23,"phases":24,"briefSummary":26,"conditions":27,"keywords":4,"overallStatus":29,"whyStopped":4,"lastUpdateSubmitDate":30,"lastUpdatePostDateStruct":31,"startDateStruct":34,"completionDateStruct":36,"leadSponsor":38,"locationsCount":41},"100646158","evaluation-of-the-effect-of-combined-use-of-cosmetic-products-for-dry-and-itchy-skin-100646158",false,"NCT07695805","Evaluation of the Effect of Combined Use of Cosmetic Products for Dry and Itchy Skin.","Confirmation in Human Subjects of a Cosmetic Product Efficacy After Application in the Body Under Normal Conditions of Use.","Inclusion Criteria:\n\n* Age: 18-70 years old\n* Gender: both\n* Sensitive skin and 30% to 50% with atopic tendency (scored 8-12)\n* With dry or very dry skin on the body\n* With presence of itching due to different origins: contact\u002Ffriction with fabrics, hard water, atopic tendency, dry skin, etc.\n\nExclusion Criteria:\n\n* cutaneous marks on the experimental areas, which could interfere with the assessment of skin reactions (pigmentation troubles, scar elements, over-developed pilosity, ephelides and naevi in too great quantity, sunburn),\n* allergy or reactivity to products of the same category than the tested one,\n* with history of malignant melanomas (Dubreullh melanosis…)\n* unbalanced hormonal treatment,\n* forecast of initiation of an hormonal treatment or change of the usual hormonal treatment during the study or 3 months before the starting of the study,\n* forecast of intensive sun or UVA exposure (UV lamps) during the test period,\n* breast-feeding or pregnancy,\n* treatment with Vitamin A acid or its derivatives stopped less than 3 months before the beginning of the study,\n* treatment with anti-stretch, firming, slimming or anti-cellulite products stopped less than 3 months before the beginning of the study,\n* diet stopped less than 3 months before the beginning of the study,\n* drugs likely to produce an increase or reduction in body weight,\n* under anti-cellulite treatment: mesotherapy, electrotherapy, ionisation, ultrasonotherapy, relaxation, acupuncture, hydrotherapy, lymphatic drainage, massage, sauna,…,\n* neither antibiotic, anti-allergic, anti-inflammatory treatment nor treatment with patent medicines containing Vitamin A acid or its derivatives before and during the study (if therapeutic requirement: exclusion foreseen),\n* systemic disorders: Cardiovascular, pulmonary, digestive, neurologic, psychiatric, genital, urinary, haematological, endocrine\n* individuals who have undergone a bilateral mastectomy with lymph node removal, a unilateral mastectomy with lymph node removal within the last year, or a bilateral axillary lymph node removal,\n* individuals with a history of immune deficiency or auto-immune disease, treated for malignancy within 6 months prior to enrollment or who are currently under treatment for asthma or diabetes,\n* forecast of vaccination during the test period or last vaccination within 3 weeks before the study",true,"ALL","18 Years","70 Years",{"count":21,"type":22},60,"ESTIMATED","INTERVENTIONAL",[25],"NA","The goal of this study is to learn if combined use of shower oleogel and body lotion works to improve skin itching and dryness in adults. It will also learn about its safety. The main question it aims to answer is:\n\n• Does the products use improves skin hydration and itching? Researchers will compare shower oleogel and body lotion to a commercially available shower gel and the body lotion to see if the combined use is more efficient than use of body lotion alone.\n\nParticipants will:\n\n* Use assigned products every day for 1 month\n* Visit the CRO for checkups and tests on established schedule",[28],"Dry Skin","NOT_YET_RECRUITING","2026-07-08",{"date":32,"type":33},"2026-07-10","ACTUAL",{"date":35,"type":22},"2026-07",{"date":37,"type":22},"2026-09",{"name":39,"class":40},"Lacer S.A.","INDUSTRY",1,{"id":43,"slug":44,"hasResults":11,"nctId":45,"briefTitle":46,"officialTitle":47,"acronym":4,"eligibilityCriteria":48,"healthyVolunteers":11,"sex":17,"minAge":18,"maxAge":49,"enrollmentInfo":50,"targetDuration":4,"studyType":23,"phases":51,"briefSummary":52,"conditions":53,"keywords":4,"overallStatus":55,"whyStopped":4,"lastUpdateSubmitDate":56,"lastUpdatePostDateStruct":57,"startDateStruct":59,"completionDateStruct":61,"leadSponsor":62,"locationsCount":41},"100630982","evaluation-of-the-effect-of-the-toothpaste-on-delicate-gums-100630982","NCT07494747","Evaluation of the Effect of the Toothpaste on Delicate Gums","Benchmark Controlled Evaluation of the Effect of a Cosmetic Product in Improving Gums Condition - in Use Test Under Dentist Control","Inclusion Criteria:\n\n1. Healthy male and female subjects (with no specific repartition)\n2. Subjects of Caucasian ethnicity\n3. Subjects aged between 18 and 65 years (extremes included)\n4. Subjects clinically showing moderate gums inflammation (gingivitis grade II, in particular all gingival scores for the mean should be between 1.75 and 2.3, according to Löe and Silness gingival scoring system), in particular:\n\n   1. 40% of the subjects with localized gingivitis (10-30% of evaluated sites with bleeding)\n   2. 60% of them with generalized gingivitis (\\>30% of evaluated sites with bleeding) Repartition to be respected in both study groups.\n5. Subjects with dental plaque (total plaque score at inclusion ≥2)\n6. Subjects registered with the national health service\n7. Subjects certifying the truthfulness of the personal data disclosed to the Principal Investigator or designated personnel\n8. Subjects able to understand the language used in the investigation centre and the information given by the Principal Investigator or designated personnel\n9. Subjects able to respect the instructions given by the Principal Investigator or designated personnel as well as able to respect the study constraints and specific requirements\n10. Subjects who commit not to change their daily routine or lifestyle during the study\n11. Subjects on stable pharmacological therapy (except for the pharmacological therapy in the non-inclusion criteria) for at least one month without any changes expected or planned during the study\n12. Subjects informed about the test procedures who have signed a consent form and privacy agreement\n\nExclusion Criteria:\n\n1. Subjects who do not meet the inclusion criteria\n2. Smokers subjects\n3. Subjects planning toothcare during the study period\n4. Subjects using dental apparatus or using dental prosthesis, with generalized tooth recession, with presence of caries, with dental abscess or signs of periodontitis (periodontal probing depth \\>3mm) or active periodontitis\n5. Subjects using other dental hygiene products than provided (e.g. dental floss, interdental brushes, mouthwash, etc) during the study period\n6. Subjects with any acute, chronic, or progressive disease or condition that may interfere with the study data or that the Principal Investigator considers dangerous to the subject or incompatible with the requirements of the study\n7. Subjects participating or planning to participate in other clinical trials\n8. Subjects who participated in a similar study without respecting an adequate washout period (at least one month)\n9. Subjects that have food intolerances or food allergies to ingredients of the study product\n10. Subjects under pharmacological treatments that are considered incompatible with the study requirement by the Principal Investigator\n11. Subjects who are currently using food supplement(s) and\u002For products with the same activity as the study product, or who haven't observed an adequate washout period (at least one month)\n12. Subjects admitted to a health or social facility\n13. Subjects planning a hospitalization during the study\n14. Subjects not able to be contacted in case of emergency\n15. Subjects deprived of freedom by administrative or legal decision or under guardianship\n16. Subjects who have or have had a history of alcohol or drug addiction\n17. Subjects with eating disorders (i.e. bulimia, psychogenic eating disorders, etc.)\n18. Subject breastfeeding, pregnant or not willing to take necessary precautions to avoid pregnancy during the study (for the women of childbearing potential).","65 Years",{"count":21,"type":22},[25],"The goal of this study is to learn if a toothpaste works to alleviate gingivitis in adults. It will also learn about the safety of the product. The main question it aims to answer is:\n\n• Does the toothpaste help to improve signs of gingivitis? Researchers will compare gingivitis toothpaste to a regular toothpaste to see if it works to improve gingivitis.\n\nParticipants will:\n\n* Use assigned toothpaste daily for 4 weeks\n* Visit the clinic on the established days during 4 weeks for check-ups and evaluation",[54],"Gingivitis","RECRUITING","2026-05-11",{"date":58,"type":33},"2026-05-14",{"date":60,"type":33},"2026-03-24",{"date":37,"type":22},{"name":39,"class":40},{"id":64,"slug":65,"hasResults":11,"nctId":66,"briefTitle":67,"officialTitle":68,"acronym":4,"eligibilityCriteria":69,"healthyVolunteers":16,"sex":17,"minAge":18,"maxAge":49,"enrollmentInfo":70,"targetDuration":4,"studyType":23,"phases":72,"briefSummary":73,"conditions":74,"keywords":4,"overallStatus":29,"whyStopped":4,"lastUpdateSubmitDate":75,"lastUpdatePostDateStruct":76,"startDateStruct":78,"completionDateStruct":80,"leadSponsor":81,"locationsCount":4},"100635378","evaluation-of-the-effect-of-the-mouthwash-on-delicate-gums-100635378","NCT07551908","Evaluation of the Effect of the Mouthwash on Delicate Gums","Evaluation of the Effect of a Cosmetic Product in Improving Gums Condition in Use Test Under Dentist Control.","Inclusion Criteria:\n\n1. Healthy male and female subjects (with no specific repartition)\n2. Subjects of Caucasian ethnicity\n3. Subjects aged between 18 and 65 years (extremes included)\n4. Subjects clinically showing moderate gums inflammation (gingivitis grade II, in particular all gingival scores for the mean should be between 1.75 and 2.3, according to Löe and Silness gingival scoring system), in particular:\n\n   1. 20% of the subjects with localized gingivitis (10-30% of evaluated sites with bleeding)\n   2. 80% of them with generalized gingivitis (\\>30% of evaluated sites with bleeding)\n5. Subjects with dental plaque (total plaque score at inclusion ≥2)\n6. Subjects registered with the national health service\n7. Subjects certifying the truthfulness of the personal data disclosed to the Principal Investigator or designated personnel\n8. Subjects able to understand the language used in the investigation centre and the information given by the Principal Investigator or designated personnel\n9. Subjects able to respect the instructions given by the Principal Investigator or designated personnel as well as able to respect the study constraints and specific requirements\n10. Subjects who commit not to change their daily routine or lifestyle during the study\n11. Subjects on stable pharmacological therapy (except for the pharmacological therapy in the non-inclusion criteria) for at least one month without any changes expected or planned during the study\n12. Subjects informed about the test procedures who have signed a consent form and privacy agreement\n\nExclusion Criteria:\n\n1. Subjects who do not meet the inclusion criteria\n2. Smokers subjects\n3. Subjects planning toothcare during the study period\n4. Subjects using dental apparatus or using dental prosthesis, with generalized tooth recession, with presence of caries, with dental abscess or signs of periodontitis (periodontal probing depth \\>3mm) or active periodontitis\n5. Subjects using other dental hygiene products than provided (e.g. dental floss, interdental brushes, mouthwash, etc) during the study period\n6. Subjects with any acute, chronic, or progressive disease or condition that may interfere with the study data or that the Principal Investigator considers dangerous to the subject or incompatible with the requirements of the study\n7. Subjects participating or planning to participate in other clinical trials\n8. Subjects who participated in a similar study without respecting an adequate washout period (at least one month)\n9. Subjects that have intolerances or allergies to ingredients of the study product Page 8 of 28 Clinical Study Protocol: EC\\_0000149\u002F2026 of 13\u002F03\u002F2026\n10. Subjects under pharmacological treatments that are considered incompatible with the study requirement by the Principal Investigator\n11. Subjects who are currently using products with the same activity as the study product, or who haven't observed an adequate washout period (at least one month)\n12. Subjects admitted to a health or social facility\n13. Subjects planning a hospitalization during the study\n14. Subjects not able to be contacted in case of emergency\n15. Subjects deprived of freedom by administrative or legal decision or under guardianship\n16. Subjects who have or have had a history of alcohol or drug addiction\n17. Subjects with eating disorders (i.e. bulimia, psychogenic eating disorders, etc.)\n18. Subject breastfeeding, pregnant or not willing to take necessary precautions to avoid pregnancy during the study (for the women of childbearing potential).",{"count":71,"type":22},30,[25],"The goal of this study is to learn if a mouthwash works to alleviate gingivitis in adults. It will also learn about the safety of the product. The main question it aims to answer is:\n\n• Does the mouthwash help to improve signs of gingivitis?\n\nParticipants will:\n\n* Use mouthwash daily for 4 weeks\n* Visit the clinic on the established days during 4 weeks for check-ups and evaluation",[54],"2026-04-22",{"date":77,"type":33},"2026-04-27",{"date":79,"type":22},"2026-04-03",{"date":35,"type":22},{"name":39,"class":40},{"id":83,"slug":84,"hasResults":11,"nctId":85,"briefTitle":86,"officialTitle":87,"acronym":4,"eligibilityCriteria":88,"healthyVolunteers":16,"sex":17,"minAge":18,"maxAge":49,"enrollmentInfo":89,"targetDuration":4,"studyType":23,"phases":91,"briefSummary":92,"conditions":93,"keywords":4,"overallStatus":29,"whyStopped":4,"lastUpdateSubmitDate":95,"lastUpdatePostDateStruct":96,"startDateStruct":98,"completionDateStruct":100,"leadSponsor":102,"locationsCount":41},"100626696","evaluation-of-the-whitening-effect-in-subjects-after-professional-tooth-cleaning-procedure-100626696","NCT07438990","Evaluation of the Whitening Effect in Subjects After Professional Tooth Cleaning Procedure","Evaluation of the Effect of a Cosmetic Product for Teeth Care in Maintaining the Whitening Effect of a Professional Dental Cleaning Performed by a Dentist - In Use Test Under Dentist Control Study","Inclusion Criteria:\n\n1. Healthy 55 subjects\n2. Subjects of caucasian ethnicity\n3. Subjects aged between 18 and 65 years (extremes included)\n4. Subjects clinically showing stains on teeth (due to smoking, tea, coffee, wine or other food that typically stain teeth)\n5. Subjects having at least one natural teeth or central superior incisors (tooth 11 and 21) with color shade at the inclusion ≥12 and ≤30 according to R20 Bleaching shade guide\n6. Subjects registered with National Health Service (NHS)\n7. Subjects certifying the truthfulness of the personal data disclosed to the Principal Investigator or designated personnel\n8. Subjects able to understand the language used in the investigation center and the information given by the Principal Investigator or designated personnel\n9. Subjects able to respect the instructions given by the Principal Investigator or designated personnel as well as able to respect the study constraints and specific requirements\n10. Subjects who commit not to change their daily routine or lifestyle during the study\n11. Subjects on stable pharmacological therapy (except for the pharmacological therapy in the non-inclusion criteria) for at least one month without any changes expected or planned during the study\n12. Subjects informed about the test procedures who have signed a consent form and privacy agreement\n\nExclusion Criteria:\n\n1. Subjects who do not meet the inclusion criteria.\n2. Subjects with all affection which could interfere with the interpretation of the results of the study\n3. Subjects planning toothcare during the study period, using dental apparatus\n4. Subjects using dental prosthesis affecting the central superior incisors, with generalized tooth recession, malocclusion or overlapping teeth in the anterior region, with presence of caries, with dental abscess or untreated gum disease, with central superior incisor (tooth 11 or 21) evaluated and filled and who performed whitening treatments less than 6 months before the study begin\n5. Subjects with any acute, chronic, or progressive disease or condition that may interfere with the study data or that the Principal Investigator considers dangerous to the subject or incompatible with the requirements of the study\n6. Subjects participating or planning to participate in other clinical trials\n7. Subjects who participated in a similar study without respecting an adequate washout period (at least one month)\n8. Subjects that have intolerances or allergies to ingredients of the study product\n9. Subjects under pharmacological treatments that are considered incompatible with the study requirement by the Principal Investigator\n10. Subjects who are currently using products with the same activity as the study product, or who haven't observed an adequate washout period (at least one month)\n11. Subjects admitted to a health or social facility\n12. Subjects planning a hospitalization during the study\n13. Subjects not able to be contacted in case of emergency\n14. Subjects deprived of freedom by administrative or legal decision or under guardianship\n15. Subjects who have or have had a history of alcohol or drug addiction\n16. Subject breastfeeding, pregnant or not willing to take necessary precautions to avoid pregnancy during the study (for the women of childbearing potential).",{"count":90,"type":22},50,[25],"The goal of this study is to learn if the toothpaste works to maintain effect of the professional tooth cleaning in adults. It will also learn about the safety of the product. The main questions it aims to answer are:\n\n• Does the toothpaste help to maintain teeth colour after professional cleaning?\n\nResearchers will compare whitening toothpaste to a regular toothpaste to see if it works to maintain effects of professional teeth cleaning.\n\nParticipants will:\n\n* Use assigned toothpaste daily for 4 weeks\n* Visit the clinic on the established days during 4 weeks for check ups and evaluation",[94],"Tooth Color","2026-02-24",{"date":97,"type":33},"2026-02-27",{"date":99,"type":22},"2026-03-01",{"date":101,"type":22},"2026-06",{"name":39,"class":40},""]